Skip to main content

Table 1 Treatment coverage by Group over time

From: Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger

Year (Y)

Study group

SAC treated

SAC total

Mean % SAC treateda

Total population treated

Total population eligible for treatment

% total population treated

Y1

A1

16,563

20,267

82

   

A2

18,986

18,809

101

   

B1

20,382

24,670

83

   

B2

25,281

30,373

83

   

C1

22,479

17,598

128

43,600

58,648

74

C2

26,373

25,133

105

57,058

83,772

68

Y2

A1

15,053

13,425

112

   

A2

13,553

14,309

95

   

B1

19,322

17,378

111

   

B2

16,345

17,227

95

   

C1

23,512

18,123

130

47,031

60,410

78

C2

33,735

25,883

130

66,671

86,287

77

Y3 Treatment 1

A1

23,281

23,021

101

   

A2

25,174

23,586

107

   

B1

28,406

22,999

124

   

B2

33,231

27,781

120

   

C1

26,306

19,663

134

51,598

52,434

98

C2

39,311

24,415

161

74,558

65,106

115

Y3 Treatment 2

A1

0

23,021

    

A2

28,203

23,586

120

   

B1

0

22,999

    

B2

25,274

27,781

91

   

C1

0

19,663

  

52,434

 

C2

33,003

24,415

135

61,182

65,106

94

Y4 Treatment 1

A1

20,708

25,368

82

   

A2

18,178

21,528

85

   

B1

27,316

29,813

92

   

B2

29,202

33,822

86

   

C1

22,664

19,042

120

42,464

50,761

84

C2

33,861

25,866

131

55,831

68,967

81

Y4 Treatment 2

A1

0

25,368

    

A2

16,309

21,528

76

   

B1

0

29,813

    

B2

26,247

33,822

78

   

C1

0

19,042

  

50,761

 

C2

29,290

25,866

113

54,539

68,967

79

  1. aArithmetic mean weighted by village SAC population